Jeff Edelson, MD
Chief Medical Officer
Dr. Jeff Edelson has more than 30 years of drug development experience, having served in senior clinical R&D roles for several biotech and pharmaceutical firms including SmithKline Beecham, Therion Biologics, GlaxoSmithKline, Aventis and Johnson and Johnson Pharmaceutical Research and Development, where he was most recently the Therapeutic Area Head of Novel Therapeutics. He has experience developing immuno-oncology products, including cancer vaccines, as well as products for pulmonary, immunology, neurology, and therapeutic oncology across all phases of development. Dr. Edelson earned his MD at the University of Toronto.